RecruitingNCT03099681

An Observational Study on Epithelioid Sarcoma

Epithelioid Sarcoma. An Observational Study


Sponsor

Italian Sarcoma Group

Enrollment

100 participants

Start Date

Aug 22, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)


Eligibility

Plain Language Summary

Simplified for easier understanding

This is an observational study collecting information about patients with a rare cancer called epithelioid sarcoma — a type of soft tissue cancer — to better understand how it behaves and how patients respond to treatments. **You may be eligible if...** - You have been diagnosed with epithelioid sarcoma, confirmed by a tissue biopsy according to 2014 World Health Organization standards - You are willing to sign a consent form - You are able to attend follow-up visits and comply with study requirements - There is no age limit — children and adults are welcome **You may NOT be eligible if...** - You have been diagnosed with another cancer in the past 5 years (except for non-invasive cervical cancer or certain skin cancers that were fully treated) - You are unable to comply with study visits or follow-up requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTreatment for Epitheloid Sarcoma

Treatment Epitheloid Sarcoma according the disease guideline


Locations(11)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST

Meldola, FC, Italy

Istituto Europeo di Oncologia

Milan, MI, Italy

Istituto Clinico Humanitas

Rozzano, MI, Italy

Azienda Ospedaliera Universitaria Paolo Giaccone

Palermo, PA, Italy

Fondazione del Piemonte per l'Oncologia IRCC Candiolo

Candiolo, Torino, Italy

Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors

Bologna, Italy

Fondazione IRCCS INT Milano

Milan, Italy

Irccs Istituto Oncologico Veneto (Iov)

Padova, Italy

Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4

Prato, Italy

Campus Biomedico

Roma, Italy

Istituti Fisioterapici Ospitalieri di Roma

Roma, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03099681


Related Trials